Christina Kay

2023

In 2023, Christina Kay earned a total compensation of $301.3K as Co, Chief Executive Officer at Integrated Biopharma, a 9% increase compared to previous year.

Compensation breakdown

Bonus$6,400
Option Awards$48,225
Salary$237,273
Other$9,417
Total$301,315
78.75%

Kay received $237.3K in salary, accounting for 79% of the total pay in 2023.

Kay also received $6.4K in bonus, $48.2K in option awards and $9.4K in other compensation.

Rankings

In 2023, Christina Kay's compensation ranked 2,530th out of 3,006 executives tracked by ExecPay. In other words, Kay earned more than 15.8% of executives.

ClassificationRankingPercentile
All
2,530
out of 3,006
16th
Division
Manufacturing
1,414
out of 1,650
14th
Major group
Chemicals And Allied Products
817
out of 918
11th
Industry group
Drugs
797
out of 881
10th
Industry
Pharmaceutical Preparations
570
out of 637
11th
Source: SEC filing on October 27, 2023.

Kay's colleagues

We found three more compensation records of executives who worked with Christina Kay at Integrated Biopharma in 2023.

2023

Dina Masi

Integrated Biopharma

Chief Financial Officer

2023

Riva Sheppard

Integrated Biopharma

Chief Executive Officer

2023

E Kay

Integrated Biopharma

Chairman

News

You may also like